Literature DB >> 16887433

Ghrelin levels in young children with Prader-Willi syndrome.

Christine R Erdie-Lalena1, Vanja A Holm, Patrick C Kelly, R Scott Frayo, David E Cummings.   

Abstract

OBJECTIVE: To explore the hypothesis that high ghrelin levels contribute to obesity in Prader-Willi syndrome (PWS), we assessed whether the increased levels observed in older persons with PWS exist in very young children, before the onset of hyperphagia. STUDY
DESIGN: We measured ghrelin levels in nine children with PWS (17-60 months of age) and eight healthy control subjects of equivalent body mass index (BMI), age, and sex.
RESULTS: PWS and control groups had equivalent BMI (16.8 +/- 1.4 vs 16.1 +/- 0.9 kg/m(2), respectively; P = .24), age (37.8 +/- 15.4 vs 50.3 +/- 17.7 months; P = .14), and sex. PWS and control groups also had equivalent fasting levels of total ghrelin (787 +/- 242 vs 716 +/- 135 pg/mL, respectively; P = .24), bioactive ghrelin (102 +/- 35 vs 91 +/- 23 pg/mL; P = .45), insulin, and glucose. Ghrelin correlated negatively with BMI among controls (r = -0.760, P = .029) but not PWS (r = 0.015, P = .97).
CONCLUSIONS: Children <5 years of age with PWS, who had not yet developed hyperphagia or excessive obesity, had normal ghrelin levels, in contrast with the hyperghrelinemia of older, hyperphagic people with PWS. It is possible that ghrelin levels increase suddenly before hyperphagia develops.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887433     DOI: 10.1016/j.jpeds.2006.04.011

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study.

Authors:  Aayed R Alqahtani; Mohamed O Elahmedi; Awadh R Al Qahtani; Jaehoon Lee; Merlin G Butler
Journal:  Surg Obes Relat Dis       Date:  2015-07-22       Impact factor: 4.734

2.  Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.

Authors:  Frederick A Kweh; Jennifer L Miller; Carlos R Sulsona; Clive Wasserfall; Mark Atkinson; Jonathan J Shuster; Anthony P Goldstone; Daniel J Driscoll
Journal:  Am J Med Genet A       Date:  2014-10-29       Impact factor: 2.802

3.  Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.

Authors:  Andrea M Haqq; Michael Muehlbauer; Laura P Svetkey; Christopher B Newgard; Jonathan Q Purnell; Steven C Grambow; Michael S Freemark
Journal:  Clin Endocrinol (Oxf)       Date:  2007-07-30       Impact factor: 3.478

Review 4.  Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy.

Authors:  Krystal A Irizarry; Mark Miller; Michael Freemark; Andrea M Haqq
Journal:  Adv Pediatr       Date:  2016-08

5.  Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development.

Authors:  Andrea M Haqq; Steven C Grambow; Michael Muehlbauer; Christopher B Newgard; Laura P Svetkey; Aaron L Carrel; Jack A Yanovski; Jonathan Q Purnell; Michael Freemark
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-15       Impact factor: 3.478

Review 6.  Structure and physiological actions of ghrelin.

Authors:  Christine Delporte
Journal:  Scientifica (Cairo)       Date:  2013-11-28

7.  Weight control and behavior rehabilitation in a patient suffering from Prader Willi syndrome.

Authors:  Rosaria Di Lorenzo; Sara Sberveglieri; Donatella Marrama; Giulia Landi; Paola Ferri
Journal:  BMC Res Notes       Date:  2016-04-01

8.  Paradoxical leanness in the imprinting-centre deletion mouse model for Prader-Willi syndrome.

Authors:  David M Golding; Daniel J Rees; Jennifer R Davies; Dinko Relkovic; Hannah V Furby; Irina A Guschina; Anna L Hopkins; Jeffrey S Davies; James L Resnick; Anthony R Isles; Timothy Wells
Journal:  J Endocrinol       Date:  2016-10-31       Impact factor: 4.286

Review 9.  Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.

Authors:  G Muscogiuri; L Barrea; F Faggiano; M I Maiorino; M Parrillo; G Pugliese; R M Ruggeri; E Scarano; S Savastano; A Colao
Journal:  J Endocrinol Invest       Date:  2021-04-23       Impact factor: 4.256

Review 10.  Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.

Authors:  Felipe Correa-da-Silva; Eric Fliers; Dick F Swaab; Chun-Xia Yi
Journal:  J Neuroendocrinol       Date:  2021-06-22       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.